{
  "id": "2247620371_1",
  "title": "默沙东、罗氏、拜耳接连折戟，国内药企能否在这一潜力靶点成功突围？",
  "content": "<div class=\"rich_media_content js_underline_content autoTypeSetting24psection\" id=\"js_content\">\n <section nodeleaf=\"\" style=\"text-align: center;margin-left: 8px;margin-right: 8px;\">\n  <img class=\"rich_pages wxw-img\" data-imgfileid=\"100134991\" data-ratio=\"0.42340425531914894\" data-s=\"300,640\" data-type=\"png\" data-w=\"940\" src=\"/static/res/logo/https://mmbiz.qpic.cn/mmbiz_png/lVFg8Ny0F8sEopW5Xekud7JicHnPibBhUqrlCrCB2npo4f3AJxr0bcbc9URAQ6yZIsCicGUFjgx2y0wPet197e9kw/640?wx_fmt=png&amp;from=appmsg\" type=\"block\"/>\n </section>\n <p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;margin-bottom: 24px;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    在实体瘤靶向治疗的探索版图中，间皮素\n   </span>\n   <span style=\"font-size: 15px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    （Mesothelin, MSLN）\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    因其高度特异性的表达谱和多元的分子机制，正逐渐成为一颗引人瞩目的「潜力之星」，全球管线布局涵盖\n   </span>\n  </span>\n  <span style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;font-size: 15px;visibility: visible;\">\n   <span data-pm-slice='1 1 [\"para\",{\"tagName\":\"p\",\"attributes\":{\"style\":\"-webkit-tap-highlight-color: transparent;margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;clear: both;min-height: 1em;color: rgba(0, 0, 0, 0.9);font-family: \\\"PingFang SC\\\", system-ui, -apple-system, BlinkMacSystemFont, \\\"Helvetica Neue\\\", \\\"Hiragino Sans GB\\\", \\\"Microsoft YaHei UI\\\", \\\"Microsoft YaHei\\\", Arial, sans-serif;font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;line-height: 1.75em;visibility: visible;\",\"data-pm-slice\":\"0 0 []\",\"data-mpa-action-id\":\"mbos2f431iko\"},\"namespaceURI\":\"http://www.w3.org/1999/xhtml\"},\"node\",{\"tagName\":\"span\",\"attributes\":{\"style\":\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;font-size: 15px;visibility: visible;\"},\"namespaceURI\":\"http://www.w3.org/1999/xhtml\"}]' leaf=\"\">\n    免疫毒素疗法、单抗、疫苗、ADC 和细胞疗法等。\n   </span>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;margin-bottom: 24px;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    然而\n   </span>\n  </span>\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    ，这颗新星的升腾之路布满荆棘，默沙东、罗氏、拜耳等制药巨头纷纷折戟，全球迄今无一成功上市，最高研发阶段尚处于临床 II 期。而国内药企正以突破性进展悄然改写此困局。\n   </span>\n  </span>\n </p>\n <p data-mpa-action-id=\"mbos2f431v6f\" style='-webkit-tap-highlight-color: transparent;margin: 0px 8px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgba(0, 0, 0, 0.9);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;line-height: 1.75em;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span style=\"-webkit-tap-highlight-color: transparent;margin-top: 0px;margin-right: 0px;margin-left: 0px;padding: 0px;outline: 0px;max-width: 100%;font-size: 15px;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span style='-webkit-tap-highlight-color: transparent;margin-top: 0px;margin-right: 0px;margin-left: 0px;padding: 0px;outline: 0px;max-width: 100%;font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);font-size: 15px;letter-spacing: 0.034em;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n    <span style=\"letter-spacing: 0.034em;font-size: 15px;\">\n     <span leaf=\"\">\n      <br/>\n     </span>\n    </span>\n   </span>\n  </span>\n </p>\n <p data-mpa-action-id=\"mbos2f43ytc\" style='-webkit-tap-highlight-color: transparent;margin: 0px 8px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgba(0, 0, 0, 0.9);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: center;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;line-height: 1.75em;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span style=\"-webkit-tap-highlight-color: transparent;margin-top: 0px;margin-right: 0px;margin-left: 0px;padding: 0px;outline: 0px;max-width: 100%;font-size: 15px;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span style='-webkit-tap-highlight-color: transparent;margin-top: 0px;margin-right: 0px;margin-left: 0px;padding: 0px;outline: 0px;max-width: 100%;font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);font-size: 15px;letter-spacing: 0.034em;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n    <span style=\"letter-spacing: 0.034em;font-size: 15px;\">\n     <span leaf=\"\">\n      <img class=\"rich_pages wxw-img\" data-backh=\"52\" data-backw=\"463\" data-imgfileid=\"502448861\" data-ratio=\"0.11296296296296296\" data-type=\"png\" data-w=\"1080\" height=\"52\" src=\"/static/res/logo/https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZaqU9L6wBSPRicxbyNQUGkONWicTcnJOwMEFTtWTw62FMicjoVatWfAvaicG6L4TcSgNlgR0Q54oPWYdg/640?wx_fmt=png&amp;from=appmsg\" style=\"font-family: 等线;font-size: 16px;letter-spacing: 0.578px;width: 1080px;\" width=\"463\"/>\n     </span>\n    </span>\n   </span>\n  </span>\n </p>\n <p data-mpa-action-id=\"mbos2f43dna\" style=\"margin-right: 8px;margin-left: 8px;letter-spacing: 0.578px;line-height: 1.75em;text-align: center;margin-bottom: 24px;\">\n  <span style=\"color:#00b4cc;\">\n   <strong>\n    <span leaf=\"\">\n     肿瘤治疗新靶点\n    </span>\n   </strong>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    MSLN 是一种糖基磷脂酰肌醇\n   </span>\n   <span style=\"font-size: 15px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    （GPI）\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    锚定的细胞表面糖蛋白，最早在 1992 年被发现特异性表达于卵巢癌细胞，而\n   </span>\n  </span>\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    除胸膜、腹膜和心包膜间皮细胞外的正常人体组织中几乎不表达\n   </span>\n  </span>\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    ，故得名为间皮素。\n   </span>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    后续更多的证据显示，\n   </span>\n  </span>\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    MSLN 的异常表达并不仅限于卵巢癌，其在多种实体瘤中均呈现过表达，包括肺癌、胰腺癌、胃癌、胆管癌以及恶性间皮瘤等。与正常组织中的低表达水平相比，MSLN 在肿瘤组织中的这种高度选择性过表达，为肿瘤特异性靶向治疗提供了理想的理论基础。\n   </span>\n  </span>\n </p>\n <section nodeleaf=\"\" style=\"text-align: center;margin-left: 8px;margin-right: 8px;margin-bottom: 0px;\">\n  <img class=\"rich_pages wxw-img\" data-imgfileid=\"100135997\" data-ratio=\"0.7305825242718447\" data-s=\"300,640\" data-type=\"png\" data-w=\"824\" src=\"/static/res/logo/https://mmbiz.qpic.cn/mmbiz_png/lVFg8Ny0F8v5zEgibgFwwGzFnU6oCiakd57OoXKibHBMsOrBkJQv4y46RkcWLic9Vn4rAhGmD3S1G8icMCMk4g7SsLQ/640?wx_fmt=png&amp;from=appmsg\" type=\"block\"/>\n </section>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;text-align: center;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 12px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    截图来源：《Cancer discovery》（\n   </span>\n  </span>\n  <span leaf=\"\">\n   <span style=\"font-size: 12px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    PMID: 26503962\n   </span>\n  </span>\n  <span leaf=\"\">\n   <span style=\"font-size: 12px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    ）\n   </span>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    目前研究发现，MSLN 在肿瘤中发生发展的作用机制复杂而多元。\n   </span>\n  </span>\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    异常的 MSLN 表达促进肿瘤细胞的增殖和侵袭。同时，MSLN 也被证实与 CA125 相互作用介导细胞粘附，在卵巢癌细胞腹膜转移中起到重要作用。\n   </span>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    从信号通路来看，MSLN 的过表达可以激活 NFκB、MAPK 和 PI3K 通路，增强对细胞凋亡的抵抗，或诱导 MMP7 和 MMP9 的表达来促进细胞增殖、迁移和侵袭。\n   </span>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    总的来说，MSLN 在肿瘤中的特异性高表达以及驱动肿瘤发生发展的多重机制，使其成为了一个极具潜力的肿瘤治疗新靶点。\n   </span>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 0px;line-height: 1.75em;\">\n  <span leaf=\"\">\n   <br/>\n  </span>\n </p>\n <p data-mpa-action-id=\"mbos2f43ytc\" data-pm-slice=\"5 2 []\" style='-webkit-tap-highlight-color: transparent;margin: 0px 8px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgba(0, 0, 0, 0.9);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: center;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;line-height: 1.75em;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span style=\"-webkit-tap-highlight-color: transparent;margin-top: 0px;margin-right: 0px;margin-left: 0px;padding: 0px;outline: 0px;max-width: 100%;font-size: 15px;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span style='-webkit-tap-highlight-color: transparent;margin-top: 0px;margin-right: 0px;margin-left: 0px;padding: 0px;outline: 0px;max-width: 100%;font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);font-size: 15px;letter-spacing: 0.034em;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n    <span style=\"letter-spacing: 0.034em;font-size: 15px;\">\n     <span leaf=\"\">\n      <img class=\"rich_pages wxw-img\" data-backh=\"52\" data-backw=\"463\" data-imgfileid=\"502448861\" data-ratio=\"0.11296296296296296\" data-type=\"png\" data-w=\"1080\" height=\"52\" src=\"/static/res/logo/https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZaqU9L6wBSPRicxbyNQUGkONWicTcnJOwMEFTtWTw62FMicjoVatWfAvaicG6L4TcSgNlgR0Q54oPWYdg/640?wx_fmt=png&amp;from=appmsg\" style=\"font-family: 等线;font-size: 16px;letter-spacing: 0.578px;width: 1080px;\" width=\"463\"/>\n     </span>\n    </span>\n   </span>\n  </span>\n </p>\n <p data-mpa-action-id=\"mbos2f43dna\" style=\"margin-right: 8px;margin-left: 8px;letter-spacing: 0.578px;line-height: 1.75em;text-align: center;margin-bottom: 24px;\">\n  <span style=\"color:#00b4cc;\">\n   <strong>\n    <span leaf=\"\">\n     巨头折戟\n    </span>\n   </strong>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    MSLN 作为颇具潜力的肿瘤靶点，其蕴含的临床价值持续吸引着全球制药巨头重兵布局，\n   </span>\n   <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n    罗氏、默沙东、拜耳、BMS\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    等纷纷投身其中。然而，MSLN 靶向药物的研发征程堪称荆棘密布。\n   </span>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    从研发进度看，拜耳的 Anetumab Ravtansine\n   </span>\n   <span style=\"font-size: 15px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    （研发代号：BAY 94-9343）\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    曾是最具希望的 MSLN ADC 之一。该药物采用全人源抗间皮素抗体，通过可裂解连接子与强效微管蛋白抑制剂 DM4 偶联，DAR 为 3.2。\n   </span>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    I 期临床试验结果显示，在包括间皮瘤、卵巢癌、胰腺癌等多种接受过大量治疗的间皮素高表达实体瘤患者中，Anetumab Ravtansine 显示出可控的安全性和初步的抗肿瘤活性信号。\n   </span>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    然而，当推进至 II 期临床阶段时，其在\n   </span>\n   <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n    卵巢癌\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    和\n   </span>\n   <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n    恶性胸膜间皮瘤\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    患者中的表现却令人失望，\n   </span>\n   <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n    其疗效数据或劣于对照组，或未能展现出统计学意义的显著差异。\n   </span>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    同样是较早入局的默沙东，曾和 Aduro BioTech 携手启动 MSLN 靶向疫苗 CRS-207 与帕博利珠单抗联合治疗的两项 II 期临床试验，分别瞄准\n   </span>\n   <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n    恶性胸膜间皮瘤\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    和\n   </span>\n   <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n    胃癌\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    。然而，这两项临床均因为入组率低且\n   </span>\n   <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n    缺乏临床活性\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    而被终止。\n   </span>\n  </span>\n </p>\n <section nodeleaf=\"\" style=\"text-align: center;margin-left: 8px;margin-right: 8px;margin-bottom: 0px;\">\n  <img class=\"rich_pages wxw-img\" data-imgfileid=\"100136252\" data-ratio=\"0.03148148148148148\" data-s=\"300,640\" data-type=\"png\" data-w=\"1080\" src=\"/static/res/logo/https://mmbiz.qpic.cn/mmbiz_png/lVFg8Ny0F8veEoaITIYHQKpWAydG8Fv2cHVBYpEoAwxPTp8ozUACOa6NHD8DtLdLN5egg6cIWCxtzR8eNdNicibQ/640?wx_fmt=png&amp;from=appmsg\" type=\"block\"/>\n </section>\n <section nodeleaf=\"\" style=\"text-align: center;margin-left: 8px;margin-right: 8px;margin-bottom: 0px;\">\n  <img class=\"rich_pages wxw-img\" data-imgfileid=\"100136251\" data-ratio=\"0.225\" data-s=\"300,640\" data-type=\"png\" data-w=\"1080\" src=\"/static/res/logo/https://mmbiz.qpic.cn/mmbiz_png/lVFg8Ny0F8veEoaITIYHQKpWAydG8Fv2s0eX5V7wWkHrKjSfawYHhGdrias8YKXOrxf6YiaVszShRK1vvicFE6yXg/640?wx_fmt=png&amp;from=appmsg\" type=\"block\"/>\n </section>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;text-align: center;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 12px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    截图来源：Insight 数据库\n   </span>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    罗氏则押注于一款重组免疫毒素 LMB-100。该药物可与 MSLN 结合，并带有一种强效的细菌毒素。然而在一项针对\n   </span>\n   <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n    胰腺癌\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    的 II 期临床试验中，LMB-100 因为\n   </span>\n   <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n    严重的安全性问题\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    亮起红灯，提前终止了研究。\n   </span>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    众多巨头的相继受挫，无疑为 MSLN 靶向治疗领域蒙上了一层阴影，不断考验着后继者的研发能力和信心。\n   </span>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 0px;line-height: 1.75em;\">\n  <span leaf=\"\">\n   <br/>\n  </span>\n </p>\n <p data-mpa-action-id=\"mbos2f43ytc\" data-pm-slice=\"5 2 []\" style='-webkit-tap-highlight-color: transparent;margin: 0px 8px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgba(0, 0, 0, 0.9);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: center;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;line-height: 1.75em;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span style=\"-webkit-tap-highlight-color: transparent;margin-top: 0px;margin-right: 0px;margin-left: 0px;padding: 0px;outline: 0px;max-width: 100%;font-size: 15px;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span style='-webkit-tap-highlight-color: transparent;margin-top: 0px;margin-right: 0px;margin-left: 0px;padding: 0px;outline: 0px;max-width: 100%;font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);font-size: 15px;letter-spacing: 0.034em;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n    <span style=\"letter-spacing: 0.034em;font-size: 15px;\">\n     <span leaf=\"\">\n      <img class=\"rich_pages wxw-img\" data-backh=\"52\" data-backw=\"463\" data-imgfileid=\"502448861\" data-ratio=\"0.11296296296296296\" data-type=\"png\" data-w=\"1080\" height=\"52\" src=\"/static/res/logo/https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZaqU9L6wBSPRicxbyNQUGkONWicTcnJOwMEFTtWTw62FMicjoVatWfAvaicG6L4TcSgNlgR0Q54oPWYdg/640?wx_fmt=png&amp;from=appmsg\" style=\"font-family: 等线;font-size: 16px;letter-spacing: 0.578px;width: 1080px;\" width=\"463\"/>\n     </span>\n    </span>\n   </span>\n  </span>\n </p>\n <p data-mpa-action-id=\"mbos2f43dna\" style=\"margin-right: 8px;margin-left: 8px;letter-spacing: 0.578px;line-height: 1.75em;text-align: center;margin-bottom: 24px;\">\n  <span style=\"color:#00b4cc;\">\n   <strong>\n    <span leaf=\"\">\n     国产突围\n    </span>\n   </strong>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    尽管 MNC 在 MSLN 死亡之谷中艰难跋涉，全球仍有众多药企前赴后继，其中国内药企锋芒渐露，尤其在 ADC 和细胞治疗领域展现出创新活力。\n   </span>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    荣昌生物的 RC88 是一种具有\n   </span>\n   <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n    first-in-class 潜力\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    的 MSLN ADC，采用了其自主研发的创新桥接技术连接 MSLN 靶向抗体以及小分子细胞毒素\n   </span>\n   <span style=\"font-size: 15px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    (MMAE)\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    ，可有效地将细胞毒素定向传递给癌细胞，实现较好的肿瘤杀灭效果。\n   </span>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    2024 年 ASCO 大会上，荣昌生物首次公布了 RC88 单药治疗 MSLN 表达的晚期实体瘤的 I/II 期临床研究结果。该项研究纳入了标准治疗失败的 MSLN 表达晚期恶性实体瘤患者，主要终点是基于 RECISTv1.1 标准的 ORR。\n   </span>\n  </span>\n </p>\n <ul class=\"list-paddingleft-1\" style=\"list-style-type: circle;\">\n  <li>\n   <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 0px;line-height: 1.75em;\">\n    <span leaf=\"\">\n     <span style=\"font-size: 15px;\" textstyle=\"\">\n      在接受过 2 至 4 线既往治疗的 31 例卵巢癌患者中\n     </span>\n     <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n      ，ORR 和确认的 ORR 分别为 45.2% 和 41.9%，中位 DoR 为 8.02 个月\n     </span>\n     <span style=\"font-size: 15px;\" textstyle=\"\">\n      。与目前的标准治疗方案\n     </span>\n     <span style=\"font-size: 15px;color: rgb(178, 178, 178);\" textstyle=\"\">\n      （ORR 为 12%）\n     </span>\n     <span style=\"font-size: 15px;\" textstyle=\"\">\n      相比，RC88 具有显著改善 MSLN 表达的晚期实体瘤患者预后方面的潜力。\n     </span>\n    </span>\n   </p>\n  </li>\n  <li>\n   <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 0px;line-height: 1.75em;\">\n    <span leaf=\"\">\n     <span style=\"font-size: 15px;\" textstyle=\"\">\n      在 16 例 EGFR/ALK 野生型非鳞状非小细胞肺癌患者中，\n     </span>\n     <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n      ORR 和 cORR 分别为 31.3% 和 25%\n     </span>\n     <span style=\"font-size: 15px;\" textstyle=\"\">\n      。其中 12 名 MSLN 高表达\n     </span>\n     <span style=\"font-size: 15px;color: rgb(178, 178, 178);\" textstyle=\"\">\n      （PS2#≥50）\n     </span>\n     <span style=\"font-size: 15px;\" textstyle=\"\">\n      患者的\n     </span>\n     <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n      ORR、cORR、中位 PFS 和中位 DoR 分别为 41.7%、33.3%、6.87 个月和 9.13 个月\n     </span>\n     <span style=\"font-size: 15px;\" textstyle=\"\">\n      。\n     </span>\n    </span>\n   </p>\n  </li>\n  <li>\n   <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;\">\n    <span leaf=\"\">\n     <span style=\"font-size: 15px;\" textstyle=\"\">\n      18 例曾接受过系统治疗的宫颈癌患者的\n     </span>\n     <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n      ORR 和 cORR 分别为 33.3% 和 27.8%\n     </span>\n     <span style=\"font-size: 15px;\" textstyle=\"\">\n      ，其中在既往接受过≥ 2 线治疗的 12 名患者中，\n     </span>\n     <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n      ORR 和 cORR 分别为 41.7% 和 33.3%\n     </span>\n     <span style=\"font-size: 15px;\" textstyle=\"\">\n      。\n     </span>\n    </span>\n   </p>\n  </li>\n </ul>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    除了单药治疗以外，荣昌生物还拓展了联用策略。2023 年，分别与\n   </span>\n   <span style=\"font-size: 15px;font-weight: normal;\" textstyle=\"\">\n    信达和君实\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    达成合作，\n   </span>\n   <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n    探索 RC88 与信迪利单抗或特瑞普利单抗联用的临床潜力\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    。\n   </span>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    另外，和铂医药同样拥有一款 MSLN ADC 药物 HBM9033\n   </span>\n   <span style=\"font-size: 15px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    （PF-0805266）\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    。该药物在分子设计上由全人源 IgG1 单克隆抗体与基于喜树碱的强效 TOP1i 载荷，通过可被蛋白酶裂解的连接子连接而成，DAR 均值达到 8，旨在解决以往靶向 MSLN ADC 疗法的局限性。\n   </span>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    2023 年 12 月，辉瑞以\n   </span>\n   <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n    11.3 亿美元\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    获得了该药的全球临床开发和商业化权利。次年 6 月，辉瑞启动首个 HBM9033 针对晚期实体瘤的 I 期开放标签、多中心研究。2025 年 AACR 大会上，辉瑞公布了该药的临床前数据。\n   </span>\n  </span>\n </p>\n <ul class=\"list-paddingleft-1\" style=\"list-style-type: circle;\">\n  <li>\n   <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 0px;line-height: 1.75em;\">\n    <span leaf=\"\">\n     <span style=\"font-size: 15px;\" textstyle=\"\">\n      体外研究显示， HBM9033 能\n     </span>\n     <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n      有效杀伤\n     </span>\n     <span style=\"font-size: 15px;\" textstyle=\"\">\n      MSLN 阳性细胞，并通过「旁观者效应」杀伤共培养的 MSLN 阴性细胞。即使在生理浓度可溶性 MSLN 存在下，HBM9033 仍具备细胞杀伤能力。\n     </span>\n    </span>\n   </p>\n  </li>\n  <li>\n   <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;\">\n    <span leaf=\"\">\n     <span style=\"font-size: 15px;\" textstyle=\"\">\n      体内研究显示，在多种肿瘤模型\n     </span>\n     <span style=\"font-size: 15px;color: rgb(178, 178, 178);\" textstyle=\"\">\n      （卵巢癌、肺癌、结直肠癌细胞系及患者来源异种移植模型）\n     </span>\n     <span style=\"font-size: 15px;\" textstyle=\"\">\n      中，HBM9033 的\n     </span>\n     <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n      疗效均显著优于基于 DM4 的 MSLN 基准 ADC\n     </span>\n     <span style=\"font-size: 15px;\" textstyle=\"\">\n      。在由 MSLN 阳性和阴性细胞混合组成的异源移植模型中，HBM9033 也展现出更强的抗肿瘤活性和旁观者效应。\n     </span>\n    </span>\n   </p>\n  </li>\n </ul>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    细胞治疗是 MSLN 靶向领域的另一重要突破口。根据 Insight 数据库，进入临床阶段的国产 MSLN 靶向药物共 23 款，其中细胞疗法独占 21 席。除单靶点的 MSLN CAR-T 外，还有多靶点 CAR-T\n   </span>\n   <span style=\"font-size: 15px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    （如 CD40/MSLN、MSLN/PD-1/MUC1/CTLA4、\n   </span>\n  </span>\n  <span data-pm-slice='1 1 [\"para\",{\"tagName\":\"p\",\"attributes\":{\"style\":\"margin-left: 8px; margin-right: 8px; margin-bottom: 24px; line-height: 1.75em;\"},\"namespaceURI\":\"http://www.w3.org/1999/xhtml\"}]' leaf=\"\">\n   <span style=\"font-size: 15px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    MSLN/CLDN18.2\n   </span>\n  </span>\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    等）\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    以及 CAT-NK 等。\n   </span>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    2025 年 ASCO 大会上，上海细胞治疗集团开发的\n   </span>\n  </span>\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    新型非病毒 aPD1-MSLN JL-Lightning-CAR-T 疗法\n   </span>\n   <span style=\"font-size: 15px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    （\n   </span>\n  </span>\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    BZT2312\n   </span>\n  </span>\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    ）\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    展现了\n   </span>\n  </span>\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    MSLN 靶向的实体瘤治疗的突破性进展。I 期数据显示，\n   </span>\n  </span>\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    仅需 30 小时即可完成从单采血到制剂的全过程，\n   </span>\n  </span>\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    7 例入组的晚期恶性间皮瘤患者\n   </span>\n  </span>\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    ，均接受了单次静脉回输，\n   </span>\n   <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n    总体 ORR 为 57%， DCR 为 86%\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    。\n   </span>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    此外，\n   </span>\n  </span>\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    在第二剂量组\n   </span>\n   <span style=\"font-size: 15px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    （DL2，n=2）\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    ，1 例患者达到 PR ，1 例患者实现 CR，\n   </span>\n   <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n    ORR 与 DCR 均为 100%\n   </span>\n   <span style=\"font-size: 15px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    （2/2）\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    。其中，CR 患者在 3 个月时获得肿瘤完全缓解，持续 CR 已超过 12 个月。在第三剂量组\n   </span>\n   <span style=\"font-size: 15px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    （DL3，n=4）\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    ，4 例患者中有 2 例达到 PR，2 例为 SD，\n   </span>\n   <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n    ORR 为 50%\n   </span>\n   <span style=\"font-size: 15px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    （2/4）\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    ，\n   </span>\n   <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n    DCR 为 100%\n   </span>\n   <span style=\"font-size: 15px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    （4/4）\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    。\n   </span>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    除此之外，目前国内大部分项目均处于临床早期阶段，公开披露的临床数据有限。\n   </span>\n  </span>\n </p>\n <section nodeleaf=\"\" style=\"text-align: center;margin-left: 8px;margin-right: 8px;margin-bottom: 0px;\">\n  <img class=\"rich_pages wxw-img\" data-imgfileid=\"100135999\" data-ratio=\"0.9066666666666666\" data-s=\"300,640\" data-type=\"png\" data-w=\"900\" src=\"/static/res/logo/https://mmbiz.qpic.cn/mmbiz_png/lVFg8Ny0F8v5zEgibgFwwGzFnU6oCiakd5t38NNRw3yWxw32L4FQibNLJqUKiaXiaQVhzaddt9TiaYazXuvkH09YLRnQ/640?wx_fmt=png&amp;from=appmsg\" type=\"block\"/>\n </section>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;text-align: center;\">\n  <span data-pm-slice='1 1 [\"para\",{\"tagName\":\"p\",\"attributes\":{\"style\":\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;text-align: center;\"},\"namespaceURI\":\"http://www.w3.org/1999/xhtml\"}]' leaf=\"\">\n   <span style=\"font-size: 12px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    截图来源：Insight 数据库，\n   </span>\n  </span>\n  <span leaf=\"\">\n   <span style=\"font-size: 12px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    统计截止日期：2025 年 6 月 23 日\n   </span>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 0px;line-height: 1.75em;text-align: center;\">\n  <span data-pm-slice='1 1 [\"para\",{\"tagName\":\"p\",\"attributes\":{\"style\":\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;text-align: center;\"},\"namespaceURI\":\"http://www.w3.org/1999/xhtml\"}]' leaf=\"\">\n   <br/>\n  </span>\n </p>\n <p data-mpa-action-id=\"mbos2f43ytc\" data-pm-slice=\"5 2 []\" style='-webkit-tap-highlight-color: transparent;margin: 0px 8px;padding: 0px;outline: 0px;max-width: 100%;clear: both;min-height: 1em;color: rgba(0, 0, 0, 0.9);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: center;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;line-height: 1.75em;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span style=\"-webkit-tap-highlight-color: transparent;margin-top: 0px;margin-right: 0px;margin-left: 0px;padding: 0px;outline: 0px;max-width: 100%;font-size: 15px;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span style='-webkit-tap-highlight-color: transparent;margin-top: 0px;margin-right: 0px;margin-left: 0px;padding: 0px;outline: 0px;max-width: 100%;font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);font-size: 15px;letter-spacing: 0.034em;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n    <span style=\"letter-spacing: 0.034em;font-size: 15px;\">\n     <span leaf=\"\">\n      <img class=\"rich_pages wxw-img\" data-backh=\"52\" data-backw=\"463\" data-imgfileid=\"502448861\" data-ratio=\"0.11296296296296296\" data-type=\"png\" data-w=\"1080\" height=\"52\" src=\"/static/res/logo/https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZaqU9L6wBSPRicxbyNQUGkONWicTcnJOwMEFTtWTw62FMicjoVatWfAvaicG6L4TcSgNlgR0Q54oPWYdg/640?wx_fmt=png&amp;from=appmsg\" style=\"font-family: 等线;font-size: 16px;letter-spacing: 0.578px;width: 1080px;\" width=\"463\"/>\n     </span>\n    </span>\n   </span>\n  </span>\n </p>\n <p data-mpa-action-id=\"mbos2f43dna\" style=\"margin-right: 8px;margin-left: 8px;letter-spacing: 0.578px;line-height: 1.75em;text-align: center;margin-bottom: 24px;\">\n  <span style=\"color:#00b4cc;\">\n   <strong>\n    <span leaf=\"\">\n     结语\n    </span>\n   </strong>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    从靶点机制探索到临床转化应用，MSLN 靶向治疗已历经近二十年的曲折征程。从早期 MNC 的折戟沉沙，到如今国产药企凭借创新技术平台和差异化策略重整旗鼓，这一靶点正迎来价值重估的关键时期。\n   </span>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;margin-bottom: 24px;line-height: 1.75em;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    MSLN 最终能否成功突围，成为实体瘤治疗领域的又一重要靶点，还需要更多的临床数据来说话。\n   </span>\n  </span>\n </p>\n <section style='-webkit-tap-highlight-color: transparent;margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;color: rgba(0, 0, 0, 0.9);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0em;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;background-color: rgb(255, 255, 255);line-height: 1.75em;'>\n  <span style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;font-size: 15px;letter-spacing: 0.034em;\">\n  </span>\n </section>\n <section data-role=\"outer\" label=\"Powered by 135editor.com\" style='-webkit-tap-highlight-color: transparent;margin: 0px 0px 0em;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;background-color: rgb(255, 255, 255);color: rgb(34, 34, 34);caret-color: rgb(34, 34, 34);font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;'>\n  <section data-color=\"#eb6794\" style=\"-webkit-tap-highlight-color: transparent;margin: 1em auto;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;letter-spacing: 0.544px;border-width: 0px;border-style: none;border-color: initial;\">\n   <section data-mpa-action-id=\"mbofgm801ro\" data-pm-slice=\"0 0 []\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px auto 0em;padding: 1em;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;height: 10em;line-height: 1.5em;overflow: auto;background-color: rgb(240, 240, 240);\">\n    <section style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;letter-spacing: 0.578px;line-height: 1em;text-align: justify;\">\n     <span data-mpa-action-id=\"mbofgm72d14\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;font-size: 10px;color: rgb(178, 178, 178);letter-spacing: 0.5px;\">\n      <span leaf=\"\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n       参考资料：\n      </span>\n     </span>\n    </section>\n    <p style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;clear: both;min-height: 1em;letter-spacing: 0.578px;line-height: 1em;text-align: justify;\">\n     <span data-mpa-action-id=\"mboffpj8jxo\" leaf=\"\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;font-size: 10px;color: rgb(178, 178, 178);letter-spacing: 0.5px;\">\n      [1] Morello A, Sadelain M, Adusumilli PS. Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors. Cancer Discov. 2016;6(2):133-146. doi:10.1158/2159-8290.CD-15-0583\n     </span>\n    </p>\n    <p style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;clear: both;min-height: 1em;letter-spacing: 0.578px;line-height: 1em;text-align: justify;\">\n     <span leaf=\"\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;font-size: 10px;color: rgb(178, 178, 178);letter-spacing: 0.5px;\">\n      [2] Lv J, Li P. Mesothelin as a biomarker for targeted therapy. Biomark Res. 2019;7:18. Published 2019 Aug 23. doi:10.1186/s40364-019-0169-8\n     </span>\n    </p>\n    <p style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;clear: both;min-height: 1em;letter-spacing: 0.578px;line-height: 1em;text-align: justify;\">\n     <span leaf=\"\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;font-size: 10px;color: rgb(178, 178, 178);letter-spacing: 0.5px;\">\n      [3] Hagerty BL, Pegna GJ, Xu J, Tai CH, Alewine C. Mesothelin-Targeted Recombinant Immunotoxins for Solid Tumors. Biomolecules. 2020;10(7):973. Published 2020 Jun 28. doi:10.3390/biom10070973\n     </span>\n    </p>\n    <p style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;clear: both;min-height: 1em;letter-spacing: 0.578px;line-height: 1em;text-align: justify;\">\n     <span data-mpa-action-id=\"mboffpj81otv\" leaf=\"\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;font-size: 10px;color: rgb(178, 178, 178);letter-spacing: 0.5px;\">\n      [4]\n     </span>\n     <span leaf=\"\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;font-size: 10px;\">\n      <span style=\"color: rgb(178, 178, 178);font-weight: normal;\" textstyle=\"\">\n       各公司官方资料\n      </span>\n     </span>\n    </p>\n    <p style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;clear: both;min-height: 1em;text-align: justify;line-height: 1em;\">\n     <span leaf=\"\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;font-size: 10px;\">\n      <span style=\"color: rgb(178, 178, 178);font-weight: normal;\" textstyle=\"\">\n       [5]\n      </span>\n     </span>\n     <span data-mpa-action-id=\"mbofgm72w0\" leaf=\"\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;font-size: 10px;\">\n      <span style=\"color: rgb(178, 178, 178);font-weight: normal;\" textstyle=\"\">\n       Insight 数据库\n      </span>\n     </span>\n    </p>\n   </section>\n  </section>\n </section>\n <section data-mpa-action-id=\"mbos2f43w06\" style='margin-right: 8px;margin-left: 8px;-webkit-tap-highlight-color: transparent;outline: 0px;font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;letter-spacing: 0.544px;background-color: rgb(255, 255, 255);line-height: 1.75em;text-align: center;visibility: visible;margin-bottom: 24px;'>\n  <span style=\"-webkit-tap-highlight-color: transparent;outline: 0px;font-size: 12px;color: rgb(178, 178, 178);visibility: visible;\">\n  </span>\n </section>\n <section data-mpa-action-id=\"mbos2f431dzx\" style='-webkit-tap-highlight-color: transparent;margin-right: 8px;margin-bottom: 0px;margin-left: 8px;outline: 0px;letter-spacing: 0.544px;text-indent: 0em;color: rgb(34, 34, 34);font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);visibility: visible;line-height: 1.75em;'>\n  <span style=\"-webkit-tap-highlight-color: transparent;outline: 0px;font-size: 15px;visibility: visible;\">\n   <strong style=\"-webkit-tap-highlight-color: transparent;outline: 0px;letter-spacing: 0.544px;text-align: left;color: rgb(178, 178, 178);font-size: 12px;visibility: visible;\">\n    <span leaf=\"\">\n     封面来源：\n    </span>\n   </strong>\n  </span>\n  <span style='visibility: visible;font-size: 12px;text-align: left;-webkit-tap-highlight-color: transparent;outline: 0px;color: rgb(178, 178, 178);font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;letter-spacing: 0.544px;caret-color: rgba(0, 0, 0, 0);'>\n   <span leaf=\"\">\n    站酷海洛题图\n   </span>\n  </span>\n </section>\n <section data-mpa-action-id=\"mbos2f43236z\" style='-webkit-tap-highlight-color: transparent;margin-right: 8px;margin-bottom: 0px;margin-left: 8px;outline: 0px;letter-spacing: 0.544px;text-indent: 0em;color: rgb(34, 34, 34);font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);visibility: visible;line-height: 1.75em;'>\n  <span style=\"-webkit-tap-highlight-color: transparent;outline: 0px;font-size: 15px;visibility: visible;\">\n   <strong style=\"-webkit-tap-highlight-color: transparent;outline: 0px;letter-spacing: 0.544px;text-align: left;color: rgb(178, 178, 178);font-size: 12px;visibility: visible;\">\n    <span leaf=\"\">\n     免责声明：\n    </span>\n   </strong>\n   <span style=\"-webkit-tap-highlight-color: transparent;outline: 0px;letter-spacing: 0.544px;text-align: left;color: rgb(178, 178, 178);font-size: 12px;visibility: visible;\">\n    <span leaf=\"\">\n     本文仅作信息分享，不代表 Insight 立场和观点，也不作治疗方案推荐和介绍。如有需求，请咨询和联系正规医疗机构。\n    </span>\n   </span>\n  </span>\n </section>\n <section data-mpa-action-id=\"mbos2f431rb5\" style='-webkit-tap-highlight-color: transparent;margin-right: 8px;margin-bottom: 0px;margin-left: 8px;outline: 0px;letter-spacing: 0.544px;text-indent: 0em;color: rgb(34, 34, 34);font-family: system-ui, -apple-system, system-ui, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);text-align: left;visibility: visible;line-height: 1.75em;'>\n  <span leaf=\"\">\n   <br/>\n  </span>\n </section>\n <section data-mpa-action-id=\"mbos2f43wgk\" style='-webkit-tap-highlight-color: transparent;margin-right: 8px;margin-bottom: 0px;margin-left: 8px;outline: 0px;letter-spacing: 0.544px;text-indent: 0em;color: rgb(34, 34, 34);font-family: system-ui, -apple-system, system-ui, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);text-align: left;visibility: visible;line-height: 1.75em;'>\n  <strong style='-webkit-tap-highlight-color: transparent;outline: 0px;color: rgb(178, 178, 178);font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;letter-spacing: 0.544px;caret-color: rgba(0, 0, 0, 0);visibility: visible;'>\n   <span style=\"-webkit-tap-highlight-color: transparent;outline: 0px;font-size: 12px;visibility: visible;\">\n    <strong style=\"-webkit-tap-highlight-color: transparent;outline: 0px;letter-spacing: 0.544px;visibility: visible;\">\n     <span leaf=\"\">\n      编辑\n     </span>\n    </strong>\n    <span style=\"-webkit-tap-highlight-color: transparent;outline: 0px;letter-spacing: 0.544px;\">\n     <span leaf=\"\">\n      ：ccai\n     </span>\n    </span>\n   </span>\n  </strong>\n </section>\n <section data-mpa-action-id=\"mbos2f43kg9\" style='-webkit-tap-highlight-color: transparent;margin-right: 8px;margin-bottom: 0px;margin-left: 8px;outline: 0px;letter-spacing: 0.544px;text-indent: 0em;color: rgb(34, 34, 34);font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);visibility: visible;line-height: 1.75em;'>\n  <span style=\"-webkit-tap-highlight-color: transparent;outline: 0px;color: rgb(178, 178, 178);visibility: visible;\">\n   <strong style=\"-webkit-tap-highlight-color: transparent;outline: 0px;visibility: visible;\">\n    <span style=\"-webkit-tap-highlight-color: transparent;outline: 0px;font-size: 12px;visibility: visible;\">\n     <span leaf=\"\">\n      PR 稿对接\n     </span>\n    </span>\n   </strong>\n   <span style=\"-webkit-tap-highlight-color: transparent;outline: 0px;font-size: 12px;visibility: visible;\">\n    <span leaf=\"\">\n     ：微信 insightxb\n    </span>\n   </span>\n  </span>\n </section>\n <section data-mpa-action-id=\"mbos2f43abi\" style='-webkit-tap-highlight-color: transparent;margin-right: 8px;margin-bottom: 24px;margin-left: 8px;outline: 0px;letter-spacing: 0.544px;text-indent: 0em;color: rgb(34, 34, 34);font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);visibility: visible;line-height: 1.75em;'>\n  <span style=\"-webkit-tap-highlight-color: transparent;outline: 0px;color: rgb(178, 178, 178);visibility: visible;\">\n   <strong style=\"-webkit-tap-highlight-color: transparent;outline: 0px;visibility: visible;\">\n    <span style=\"-webkit-tap-highlight-color: transparent;outline: 0px;font-size: 12px;visibility: visible;\">\n     <span leaf=\"\">\n      投稿\n     </span>\n    </span>\n   </strong>\n   <span style=\"-webkit-tap-highlight-color: transparent;outline: 0px;font-size: 12px;visibility: visible;\">\n    <span leaf=\"\">\n     ：微信 insightxb；邮箱 insight@dxy.cn\n    </span>\n   </span>\n  </span>\n </section>\n <hr style='-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;color: rgba(0, 0, 0, 0.9);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;background-color: rgb(255, 255, 255);border-style: solid;border-right-width: 0px;border-bottom-width: 0px;border-left-width: 0px;border-color: rgba(0, 0, 0, 0.1);transform-origin: 0px 0px;transform: scale(1, 0.5);'/>\n <p style='-webkit-tap-highlight-color: transparent;margin: 0px 8px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;clear: both;min-height: 1em;font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0em;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;color: rgb(34, 34, 34);background-color: rgb(255, 255, 255);font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;visibility: visible;line-height: 1.75em;'>\n  <span leaf=\"\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <br/>\n  </span>\n </p>\n <section data-pm-slice=\"0 0 []\" nodeleaf=\"\" style='-webkit-tap-highlight-color: transparent;margin: 0px 8px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;caret-color: rgba(0, 0, 0, 0);color: rgb(34, 34, 34);font-family: system-ui, -apple-system, system-ui, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);line-height: 1.75em;'>\n  <img alt=\"图片\" class=\"rich_pages wxw-img\" data-backh=\"35\" data-backw=\"542\" data-before-oversubscription-url=\"https://mmbiz.qpic.cn/mmbiz_png/5dTQk9tMvZYnVllCouEEOdqo2iaqqnfQKB92kyKXnTAsX7DloH6icYmFC8LN4mwrwZXeQ5pqqwkDc38ib16FbGZpA/640?wx_fmt=png\" data-copyright=\"0\" data-imgfileid=\"100131888\" data-ratio=\"0.06388888888888888\" data-s=\"300,640\" data-type=\"png\" data-w=\"1080\" src=\"/static/res/logo/https://mmbiz.qpic.cn/mmbiz_png/5dTQk9tMvZYnVllCouEEOdqo2iaqqnfQKB92kyKXnTAsX7DloH6icYmFC8LN4mwrwZXeQ5pqqwkDc38ib16FbGZpA/640?wx_fmt=other&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp\" style='-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;vertical-align: bottom;height: auto !important;text-align: center;text-indent: 0em;color: rgb(48, 48, 48);font-size: 15px;letter-spacing: 1.5px;widows: 1;font-family: \"Helvetica Neue\", Helvetica, \"Hiragino Sans GB\", \"Microsoft YaHei\", Arial, sans-serif;display: initial;visibility: visible !important;width: 1080px !important;'/>\n </section>\n <section style='-webkit-tap-highlight-color: transparent;margin: 0px 8px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-indent: 0em;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;caret-color: rgba(0, 0, 0, 0);color: rgb(34, 34, 34);font-family: -apple-system-font, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);text-align: center;line-height: 1.75em;'>\n  <span style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;color: rgb(48, 48, 48);font-size: 15px;\">\n   <span leaf=\"\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    多样化功能、可溯源数据……\n   </span>\n  </span>\n </section>\n <section style='-webkit-tap-highlight-color: transparent;margin: 0px 8px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-indent: 0em;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;caret-color: rgba(0, 0, 0, 0);color: rgb(34, 34, 34);font-family: -apple-system-font, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);text-align: center;line-height: 1.75em;'>\n  <span style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;color: rgb(48, 48, 48);font-size: 15px;\">\n   <span leaf=\"\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    Insight 数据库网页版等你体验\n    <img alt=\"图片\" class=\"rich_pages wxw-img\" data-imgfileid=\"100131886\" data-ratio=\"1\" data-type=\"png\" data-w=\"64\" src=\"/static/res/logo/https://mmbiz.qpic.cn/sz_mmbiz_png/5dTQk9tMvZapSKkMo4zKejyF1kwocYAdDgiaHuOPBnUFhqWicIL2pJVarklchCnjDxBbdCLIt3FXvuGicJOXnON7A/640?wx_fmt=other&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;vertical-align: text-bottom;height: auto !important;display: inline-block;visibility: visible !important;width: 1080px !important;\"/>\n   </span>\n  </span>\n  <span leaf=\"\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <br/>\n  </span>\n </section>\n <section style='-webkit-tap-highlight-color: transparent;margin: 0px 8px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;orphans: 2;text-indent: 0em;text-transform: none;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;caret-color: rgba(0, 0, 0, 0);font-variant-numeric: normal;font-variant-east-asian: normal;color: rgb(34, 34, 34);font-family: -apple-system-font, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-size: 16px;background-color: rgb(255, 255, 255);widows: 1;text-align: center;letter-spacing: 1.5px;line-height: 1.75em;'>\n  <span style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;color: rgb(255, 255, 255);background-color: rgb(0, 180, 203);font-size: 15px;\">\n   <span leaf=\"\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    点击阅读原文，\n   </span>\n   <strong style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    <span leaf=\"\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n     立刻\n    </span>\n   </strong>\n   <strong style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    <span leaf=\"\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n     解锁\n    </span>\n   </strong>\n   <span leaf=\"\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n    ！\n   </span>\n  </span>\n  <span leaf=\"\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <img alt=\"图片\" class=\"rich_pages wxw-img\" data-copyright=\"0\" data-imgfileid=\"100131887\" data-ratio=\"0.125\" data-s=\"300,640\" data-type=\"png\" data-w=\"1080\" src=\"/static/res/logo/https://mmbiz.qpic.cn/mmbiz_png/5dTQk9tMvZZsSTG4CvxVOsgyYs36Biav0Peywg39IiboTfliboldm2SDTmYnbfopNhFNPQ8XXlfF9GeoNAGLRM3KQ/640?wx_fmt=other&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;vertical-align: bottom;height: auto !important;text-indent: 0em;display: initial;visibility: visible !important;width: 1080px !important;\">\n    <img alt=\"图片\" class=\"rich_pages wxw-img js_darkmode__57\" data-backh=\"120\" data-backw=\"562\" data-copyright=\"0\" data-imgfileid=\"100131885\" data-ratio=\"0.21388888888888888\" data-s=\"300,640\" data-type=\"png\" data-w=\"1080\" src=\"/static/res/logo/https://mmbiz.qpic.cn/mmbiz_png/5dTQk9tMvZZsSTG4CvxVOsgyYs36Biav0IPufv0rfuZIZObNwZ2xqviazG11ia1vlX9hQn3UEf4ExlMrllwicluZ4A/640?wx_fmt=other&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;vertical-align: bottom;height: auto !important;text-align: start;color: rgb(51, 51, 51);letter-spacing: 1px;width: 1080px !important;visibility: visible !important;\"/>\n   </img>\n  </span>\n </section>\n <p style=\"display: none;\">\n  <mp-style-type data-value=\"3\">\n  </mp-style-type>\n </p>\n</div>\n",
  "publish_time": 1750645842,
  "mp_id": "MP_WXS_3975077766",
  "pic_url": "https://mmbiz.qlogo.cn/mmbiz_jpg/lVFg8Ny0F8v5zEgibgFwwGzFnU6oCiakd5iboSBZiaAQibCRlpIdjdIyhic4UJ4iaib6b4n8nGncIWapxa8b6PNMGU9cgA/0?wx_fmt=jpeg",
  "mp_name": "Insight数据库"
}